Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
950 INR | -1.10% | -1.04% | +25.09% |
May. 09 | Transcript : Alembic Pharmaceuticals Limited, Q4 2024 Earnings Call, May 09, 2024 | |
May. 09 | Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q4 | MT |
Sales 2024 | 62.29B 750M | Sales 2025 * | 69.85B 841M | Capitalization | 187B 2.25B |
---|---|---|---|---|---|
Net income 2024 | 6.16B 74.15M | Net income 2025 * | 6.98B 84.03M | EV / Sales 2024 | 3.11 x |
Net Debt 2024 * | 2.62B 31.51M | Net cash position 2025 * | 836M 10.06M | EV / Sales 2025 * | 2.66 x |
P/E ratio 2024 |
31.4
x | P/E ratio 2025 * |
26.7
x | Employees | 14,593 |
Yield 2024 * |
0.93% | Yield 2025 * |
0.92% | Free-Float | 29.28% |
Latest transcript on Alembic Pharmaceuticals Limited
1 day | -1.10% | ||
1 week | -1.04% | ||
Current month | -4.97% | ||
1 month | -0.84% | ||
3 months | -9.39% | ||
6 months | +30.95% | ||
Current year | +25.09% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Manisha Saraf
CMP | Compliance Officer | - | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Director/Board Member | 56 | 15-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +4.59% | - | |
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 950 | -1.10% | 58,814 |
24-05-23 | 960.6 | +0.59% | 52,449 |
24-05-22 | 955 | +0.54% | 67,330 |
24-05-21 | 949.8 | -1.85% | 85,392 |
24-05-18 | 967.8 | +0.82% | 4,260 |
Delayed Quote NSE India S.E., May 24, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.09% | 2.27B | |
+38.51% | 728B | |
+33.05% | 603B | |
-6.23% | 360B | |
+18.78% | 332B | |
+1.35% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.19% | 164B |
- Stock Market
- Equities
- APLLTD Stock